GTS5:Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 420: | Line 420: | ||
|[[GTS5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]] | |[[GTS5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]] | ||
|Disease | |Disease | ||
|Ngoni Faya (trainee) + Madina Sukhanova | |||
|7/12/2023 | |||
| | | | ||
|PENDING | |||
| | | | ||
|Madina Sukhanova (Madina S) | |||
| | | | ||
| | |Named based on GTS5 book | ||
|- | |- | ||
|[[GTS5:NF2-related_schwannomatosis_(NF2)|NF2-related schwannomatosis (NF2)]] | |[[GTS5:NF2-related_schwannomatosis_(NF2)|NF2-related schwannomatosis (NF2)]] | ||
| Line 497: | Line 497: | ||
|[[GTS5:Familial_adenomatous_polyposis_(APC)|Familial adenomatous polyposis (APC)]] | |[[GTS5:Familial_adenomatous_polyposis_(APC)|Familial adenomatous polyposis (APC)]] | ||
|Disease | |Disease | ||
|Jennifer Laffin | |||
|8/20/2023 | |||
| | | | ||
|PENDING | |||
| | | | ||
|MS / LS | |||
| | | | ||
| | |Named based on GTS5 book | ||
|- | |- | ||
|[[GTS5:Gastric_Adenocarcinoma_and_Proximal_Polyposis_of_Stomach_-_GAPPS_(APC_promoter)|Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]] | |[[GTS5:Gastric_Adenocarcinoma_and_Proximal_Polyposis_of_Stomach_-_GAPPS_(APC_promoter)|Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]] | ||
| Line 581: | Line 581: | ||
| | | | ||
| | | | ||
| | |Named based on GTS5 book (page created 12/30/23) | ||
|- | |- | ||
|[[GTS5:Hereditary_gastric_and_breast_cancer_syndrome_(CDH1,_CTNNA1)|Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]] | |[[GTS5:Hereditary_gastric_and_breast_cancer_syndrome_(CDH1,_CTNNA1)|Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]] | ||
| Line 592: | Line 592: | ||
| | | | ||
| | | | ||
| | |Named based on GTS5 book (page created 12/30/23) | ||
|- | |- | ||
|[[GTS5:Hereditary_mixed_polyposis_syndrome_(GREM1)|Hereditary mixed polyposis syndrome (GREM1)]] | |[[GTS5:Hereditary_mixed_polyposis_syndrome_(GREM1)|Hereditary mixed polyposis syndrome (GREM1)]] | ||
| Line 841: | Line 841: | ||
| | | | ||
| | | | ||
| | |Named based on GTS5 book (page created 12/30/23) | ||
|- | |- | ||
|[[GTS5:Retinoblastoma_syndrome_(RB1)|Retinoblastoma syndrome (RB1)]] | |[[GTS5:Retinoblastoma_syndrome_(RB1)|Retinoblastoma syndrome (RB1)]] | ||
| Line 942: | Line 942: | ||
|[[GTS5:Constitutional_mismatch_repair_deficiency_(CMMRD)_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]] | |[[GTS5:Constitutional_mismatch_repair_deficiency_(CMMRD)_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]] | ||
|Disease | |Disease | ||
|Jennie Thurston | |||
|7/2/2023 | |||
| | | | ||
|PENDING | |||
| | | | ||
|LS | |||
| | | | ||
| | |Named based on GTS5 book | ||
|- | |- | ||
|[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]] | |[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]] | ||
|Disease | |Disease | ||
|Constance Albarracin / Katherine Geiersbach | |||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
|Katherine Geiersbach | |||
| | | | ||
| | |Named based on GTS5 book (page created 12/30/23) | ||
|- | |- | ||
|[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)|PALB2-related cancer predisposition syndrome (PALB2)]] | |[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)|PALB2-related cancer predisposition syndrome (PALB2)]] | ||
|Disease | |Disease | ||
|Constance Albarracin / Katherine Geiersbach / Jun Liao | |||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
|Katherine Geiersbach | |||
| | | | ||
| | |Named based on GTS5 book (page created 12/30/23) | ||
|- | |- | ||
|[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]] | |[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]] | ||
| Line 1,041: | Line 1,041: | ||
|[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)|Ataxia-telangiectasia syndrome (ATM)]] | |[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)|Ataxia-telangiectasia syndrome (ATM)]] | ||
|Disease | |Disease | ||
|Evin Gulbahce / Katherine Geiersbach | |||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
|Katherine Geiersbach | |||
| | | | ||
| | |Named based on GTS5 book (page created 12/30/23) | ||
|- | |- | ||
|[[GTS5:CHEK2-related_hereditary_(breast)_cancer_predisposition_syndrome_(CHEK2)|CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]] | |[[GTS5:CHEK2-related_hereditary_(breast)_cancer_predisposition_syndrome_(CHEK2)|CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]] | ||
| Line 1,059: | Line 1,059: | ||
| | | | ||
| | | | ||
| | |Named based on GTS5 book (page created 12/30/23) | ||
|- | |- | ||
|[[GTS5:Nijmegen_breakage_syndrome_(NBN)|Nijmegen breakage syndrome (NBN)]] | |[[GTS5:Nijmegen_breakage_syndrome_(NBN)|Nijmegen breakage syndrome (NBN)]] | ||
| Line 1,321: | Line 1,321: | ||
|[[GTS5:DICER1-related_tumour_predisposition_syndrome_(DICER1)|DICER1-related tumour predisposition syndrome (DICER1)]] | |[[GTS5:DICER1-related_tumour_predisposition_syndrome_(DICER1)|DICER1-related tumour predisposition syndrome (DICER1)]] | ||
|Disease | |Disease | ||
|Jennie Thurston | |||
|7/2/2023 | |||
| | | | ||
|PENDING | |||
| | | | ||
|LS | |||
| | | | ||
| | |Named based on GTS5 book | ||
|- | |- | ||
|[[GTS5:MicroRNA_processor_tumour_predisposition_syndromes_(DROSHA,_DGCR8)|MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]] | |[[GTS5:MicroRNA_processor_tumour_predisposition_syndromes_(DROSHA,_DGCR8)|MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]] | ||